Skip to main content

Table 1 Characteristics of the study groups (x ± SD)

From: NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer

Parameter

Control group

D

C

DC

No. pts.

20

20

19

19

Sex, M/F

10/10

10/10

10/9

9/10

Age, years

55.5 ± 8.1

55.4 ± 7.8

56.4 ± 8.0

56.0 ± 8.0

BMI, kg/m2

26.6 ± 2.9

27.0 ± 5.1

25.9 ± 3.3

26.3 ± 2.9

WHR, m/m

0.88 ± 0.08

0.89 ± 0.08

0.88 ± 0.09

0.87 ± 0.08

T2D, years

6.5 ± 3.1

6.7 ± 3.1

FPG, mmol/l

5.3 ± 0.7

7.2 ± 0.8*

5.5 ± 0.8

7.5 ± 0.9*

HbA1c,  %

5.4 ± 0.8

7.2 ± 0.7*

5.5 ± 0.7

7.3 ± 0.9*

Insulin, mU/l

7.8 ± 3.5

14.2 ± 1.6*

8.2 ± 4.6

21.7 ± 8.1*

HOMA-IRa

1.89 ± 1.05

4.46 ± 1.8*

1.99 ± 1.2

6.96 ± 2.8*

  1. BMI body mass index, WHR waist/hip ratio, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose
  2. Comparing the parameters of various study groups was made relative to the control group; * P < 0.01
  3. aHOMA-IR index was calculated on the basis of HOMA formula = fasting insulin (mU/l) × fasting glucose (mmol/l)/22.5